Evidence map›Paper›PMID 37139607›Full record

ArticleEMBO reports2023

Low temperature and mTOR inhibition favor stem cell maintenance in human keratinocyte cultures.

Daisuke Nanba, Jun-Ichi Sakabe, Johannes Mosig, Michel Brouard, Fujio Toki, Mariko Shimokawa, Mako Kamiya, Thomas Braschler, Fahd Azzabi, Stéphanie Droz-Georget Lathion and 6 more

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Daisuke Nanba *Laboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID 0000-0002-9765-9113
Jun-Ichi Sakabe *Duke-NUS Medical School, Singapore City, Singapore.
Johannes Mosig *Laboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.ORCID 0000-0002-9189-4219
Michel Brouard *Laboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Fujio TokiLaboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Mariko ShimokawaDivision of Aging and Regeneration, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Mako KamiyaDepartment of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Thomas BraschlerLaboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Fahd AzzabiLaboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Stéphanie Droz-Georget LathionLaboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Kai JohnssonDepartment of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Keya RoyDuke-NUS Medical School, Singapore City, Singapore.
Christoph D SchmidFriedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
Jean-Baptiste BureauLaboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Ariane RochatLaboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Yann BarrandonLaboratory of Stem Cell Dynamics, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
École Polytechnique Fédérale de Lausanne · CHAgency for Science, Technology and Research · SGUniversity of Geneva · CHFriedrich Miescher Institute · CHThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adult autologous human epidermal stem cells can be extensively expanded ex vivo for cell and gene therapy. Identifying the mechanisms involved in stem cell maintenance and defining culture conditions to maintain stemness is critical, because an inadequate environment can result in the rapid conversion of stem cells into progenitors/transient amplifying cells (clonal conversion), with deleterious consequences on the quality of the transplants and their ability to engraft. Here, we demonstrate that cultured human epidermal stem cells respond to a small drop in temperature through thermoTRP channels via mTOR signaling. Exposure of cells to rapamycin or a small drop in temperature induces the nuclear translocation of mTOR with an impact on gene expression. We also demonstrate by single-cell analysis that long-term inhibition of mTORC1 reduces clonal conversion and favors the maintenance of stemness. Taken together, our results demonstrate that human keratinocyte stem cells can adapt to environmental changes (e.g., small variations in temperature) through mTOR signaling and constant inhibition of mTORC1 favors stem cell maintenance, a finding of high importance for regenerative medicine applications.

Indexed as

KeratinocytesTOR Serine-Threonine KinasesAdultHumansMechanistic Target of Rapamycin Complex 1Stem CellsTemperatureMechanistic Target of Rapamycin Complex 1MTOR protein, humanTOR Serine-Threonine Kinaseskeratinocyte stem cellsmicroenvironmentmTORtemperatureTRP channels

Identifiers

PMID37139607
PMCPMC10240198
OpenAlexW4368358945

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.